Gene profiling and the cyclin-dependent kinase inhibitor flavopiridol: What's in a name?

被引：0
|
作者：
Grant, S
Dent, P
机构：
[1] Virginia Commonwealth Univ, Med Coll Virginia, Div Hematol Oncol, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ, Med Coll Virginia, Dept Radiat Oncol, Richmond, VA 23298 USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2004年 / 3卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：873 / 875
页数：3
相关论文
共 50 条
  • [21] Flavopiridol as cyclin dependent kinase (CDK) inhibitor: a review
    Deep, Aakash
    Marwaha, Rakesh Kumar
    Marwaha, Minakshi Gupta
    Jyoti
    Nandal, Rimmy
    Sharma, Arun Kumar
    NEW JOURNAL OF CHEMISTRY, 2018, 42 (23) : 18500 - 18507
  • [22] Pharmacodynamic assessment of the cyclin-dependent kinase inhibitor flavopiridol: Modulation of cdk targets in clinical samples
    Di Vizio, D
    O'Connell, FP
    Bhattacharya, N
    Shapiro, GI
    Loda, M
    MODERN PATHOLOGY, 2005, 18 : 297A - 297A
  • [23] The cyclin-dependent kinase inhibitor flavopiridol inhibits glycogen phosphorylase and affects glucose metabolism.
    Kaiser, AU
    Nishi, K
    Walsh, DA
    Gorin, FA
    Bradbury, EM
    Schnier, JB
    CLINICAL CANCER RESEARCH, 1999, 5 : 3754S - 3754S
  • [24] Cyclin-dependent kinase inhibitor gene polymorphisms in pituitary gigantism
    Run Yu
    Vivien Bonert
    Martha Cruz-Soto
    Shlomo Melmed
    Endocrine, 2006, 29 : 119 - 120
  • [25] Cyclin-dependent kinase inhibitor gene polymorphisms in pituitary gigantism
    Yu, R
    Bonert, V
    Cruz-Soto, M
    Melmed, S
    ENDOCRINE, 2006, 29 (01) : 119 - 120
  • [26] Flavopiridol, a cyclin-dependent kinase inhibitor, prevents spindle inhibitor-induced endoreduplication in human cancer cells
    Motwani, M
    Li, XK
    Schwartz, GK
    CLINICAL CANCER RESEARCH, 2000, 6 (03) : 924 - 932
  • [27] Amelioration of nephropathy in mice expressing HIV-1 genes by the cyclin-dependent kinase inhibitor flavopiridol
    Nelson, PJ
    D'Agati, VD
    Gries, JM
    Suarez, JR
    Gelman, IH
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (04) : 921 - 929
  • [28] Gene expression profiling of the cyclin-dependent kinase inhibitor CYC202 (R-Roscovitine)
    Whittaker, SR
    Te Poele, R
    Walton, MI
    Garrett, MD
    Workman, P
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S50 - S50
  • [29] Antitumor effects of flavopiridol, a cyclin-dependent kinase inhibitor, on human cholangiocarcinoma in vitro and in an in vivo xenograft model
    Saisomboon, Saowaluk
    Kariya, Ryusho
    Vaeteewoottacharn, Kulthida
    Wongkham, Sopit
    Sawanyawisuth, Kanlayanee
    Okada, Seiji
    HELIYON, 2019, 5 (05)
  • [30] Therapeutic Potential of the Cyclin-Dependent Kinase Inhibitor Flavopiridol on c-Myc Overexpressing Esophageal Cancer
    Hassan, Md Sazzad
    Cwidak, Nicholas
    Johnson, Chloe
    Daester, Silvio
    Eppenberger-Castori, Serenella
    Awasthi, Niranjan
    Li, Jun
    Schwarz, Margaret A.
    von Holzen, Urs
    FRONTIERS IN PHARMACOLOGY, 2021, 12
12345